Beyond the usual suspects: Positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis

Schizophrenia Bulletin

Volumn 39, Issue 4, 2013, Pages 917-922

  Moritz, Steffen ^a   Favrod, Jerome ^b,c   Andreou, Christina ^a   Morrison, Anthony P ^d   Bohn, Francesca ^a   Veckenstedt, Ruth ^a   Tonn, Peter ^a   Karow, Anne ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES WESTERN SWITZERLAND   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

adherence; antipsychotics; compliance; neuroleptics; psychosis; schizophrenia

Indexed keywords

BENZODIAZEPINE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; ATTITUDE TO ILLNESS; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; TREATMENT REFUSAL; VOICE DISORDER;

EID: 84879343704     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs005     Document Type: Article

References (36)

1. Leucht S, Arbter D, Engel RR, Kissling W, Davis JM. How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Mol Psychiatry. 2009; 14: 429-447.
2. Woo TUW, Canuso CM, Wojcik JD, BrunetteMF, Green AI. Treatment of schizophrenia. In: Schatzberg AF, Nemeroff CR, eds. Textbook of Psychopharmacology. 4th ed. Arlington, VA: American Psychiatric Publishing; 2009; 1135-1169.
3. Lambert M, Naber D. Current Schizophrenia. London: Current Medicine Group; 2009.
4. Kahn RS, Fleischhacker WW, Boter H, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 2008; 371: 1085-1097. (Pubitemid 351418005)
5. Byerly MJ, Nakonezny PA, Lescouflair E. Antipsychotic medication adherence in schizophrenia. Psychiatric Clin North Am. 2007; 30: 437-452. (Pubitemid 47284561)
6. Karow A, Czekalla J, Dittmann RW, et al. Association of subjective well-being, symptoms and side effects with compliance after 12 month treatment in schizophrenia. J Clin Psychiatry. 2007; 68: 75-80. (Pubitemid 46220127)
7. Moritz S, Peters MJV, Karow A, Deljkovic A, Tonn P, Naber D. Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients. Medical Illn. 2009; 1: 1-9.
8. Lepage M, Bodnar M, Joober R, Malla A. Is there an association between neurocognitive performance and medication adherence in first episode psychosis? Early Interv Psychiatry. 2010; 4: 189-195.
9. Kurtz MM, Baker E, Pearlson GD, Astur RS. A virtual reality apartment as a measure of medication management skills in patients with schizophrenia: a pilot study. Schizophr Bull. 2007; 33: 1162-1170. (Pubitemid 47347906)
10. Harrow M, Jobe TH. How frequent is chronic multiyear delusional activity and recovery in schizophrenia: a 20-year multi-follow-up. Schizophr Bull. 2010; 36: 192-204.
11. Wadeson H, Carpenter WT. Subjective experience of schizophrenia. Schizophr Bull. 1976; 2: 302-316.
12. Klapheck K, Nordmeyer S, Cronjager H, Naber D, Bock T. Subjective experience and meaning of psychoses: the German Subjective Sense in Psychosis Questionnaire (SUSE). Psychol Med. 2012; 42: 61-71.
13. Morrison AP, Wells A, Nothard S. Cognitive and emotional predictors of predisposition to hallucinations in non-patients. Br J Clin Psychol. 2002; 41: 259-270.
14. Morrison AP, Nothard S, Bowe SE, Wells A. Interpretations of voices in patients with hallucinations and non-patient controls: a comparison and predictors of distress in patients. Behav Res Ther. 2004; 42: 1315-1323. (Pubitemid 39285992)
15. Morrison AP, Gumley AI, Schwannauer M, Campbell M, et al. The Beliefs about Paranoia Scale: preliminary validation of a metacognitive approach to conceptualizing paranoia. Behav Cogn Psychothe. 2005; 33: 153-164. (Pubitemid 40546279)
16. Jenner JA, Rutten S, Beuckens J, Boonstra N, Sytema S. Positive and useful auditory vocal hallucinations: prevalence, characteristics, attributions, and implications for treatment. Acta Psychiatr Scan. 2008; 118: 238-245.
17. Morrison AP, Gumley AI, Ashcroft K, et al. Metacognition and persecutory delusions: tests of a metacognitive model in a clinical population and comparisons with non-patients. Br J Clin Psychol. 2011; 50: 223-233.
18. Sanjuan J, Gonzalez JC, Aguilar EJ, Leal C, van Os J. Pleasurable auditory hallucinations. Acta Psychiatr Scand. 2004; 110: 273-278. (Pubitemid 39278985)
19. Miller LJ, O'Connor E, DiPasquale T. Patients' attitudes toward hallucinations. Am J Psychiatry. 1993; 150: 584-588. (Pubitemid 23109926)
20. Jones S, Guy A, Ormrod JA. A Q-methodological study of hearing voices: a preliminary exploration of voice hearers' understanding of their experiences. Psychol Psychother. 2003; 76: 189-209. (Pubitemid 36775579)
21. Rosenheck R, Stroup S, Keefe RS, et al. Measuring outcome priorities and preferences in people with schizophrenia. Br J Psychiatry. 2005; 187: 529-536.
22. Van Putten T, Crumpton E, Yale C. Drug refusal in schizophrenia and the wish to be crazy. Arch Gen Psychiatry. 1976; 33: 1443-1446. (Pubitemid 8005002)
23. Lenzi A, Lazzerini F, Placidi GF, Cassano GB, Akiskal HS. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders. Pharmacopsychiatry. 1989; 22: 34-37. (Pubitemid 19053583)
24. Holzinger A, Loffler W, Muller P, Priebe S, Angermeyer MC. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia. J Nerv Ment Dis. 2002; 190: 597-603.
25. Pyne JM, Bean D, Sullivan G. Characteristics of patients with schizophrenia who do not believe they are mentally ill. J Nerv Ment Dis. 2001; 189: 146-153. (Pubitemid 32220996)
26. Copolov DL, Mackinnon A, Trauer T. Correlates of the affective impact of auditory hallucinations in psychotic disorders. Schizophr Bull. 2004; 30: 163-171. (Pubitemid 38568793)
27. Chadwick P, Birchwood M. Cognitive therapy for voices. In: Haddock G, Slade PD, eds. Cognitive-Behavioural Intervention with Psychotic Disorders. London: Routledge; 1996; 71-85.
28. Chadwick P, Birchwood M. The omnipotence of voices. A cognitive approach to auditory hallucinations. Br J Psychiatry. 1994; 164: 190-201. (Pubitemid 24077354)
29. Chadwick P, Birchwood M. The omnipotence of voices. II: the Beliefs About Voices Questionnaire (BAVQ). Br J Psychiatry. 1995; 166: 773-776.
30. Favrod J, Grasset F, Spreng S, Grossenbacher B, Hode Y. Benevolent voices are not so kind: the functional significance of auditory hallucinations. Psychopathology. 2004; 37: 304-308. (Pubitemid 39664285)
31. Stefanis NC, Hanssen M, Smirnis NK, et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med. 2002; 32: 347-358. (Pubitemid 34162592)
32. Birchwood M, Smith J, Drury V, Healy J, Macmillan F, Slade M. A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr Scand. 1994; 89: 62-67. (Pubitemid 24028268)
33. Angermeyer MC, Matschinger H. Public attitude towards psychiatric treatment. Acta Psychiatr Scand. 1996; 94: 326-336. (Pubitemid 26396308)
34. Schafer I, Fisher HL. Childhood trauma and posttraumatic stress disorder in patients with psychosis: clinical challenges and emerging treatments. Curr Opin Psychiatry. 2011; 24: 514-518.
35. Brett CMC, Johns LC, Peters EP, McGuire PK. The role of metacognitive beliefs in determining the impact of anomalous experiences: a comparison of help-seeking and non-helpseeking groups of people experiencing psychotic-like anomalies. Psychol Med. 2009; 39: 939-950.
36. Morrison AP, Hutton P, Wardle M, et al. Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial. Psychol Med. In press.